SEC Form 4 · accession 0001162194-17-000144
STANDARD BIOTOOLS INC. · LAB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Vikram Jog
Officer — CHIEF FINANCIAL OFFICER
Period of report
Sep 20, 2017
Accepted (ET)
Sep 22, 2017 · 9:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001162194
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F2,F1 | $14.60 | Sep 20, 2017 | D | 3,334 | D | — | May 17, 2021 | Common Stock | 3,334 | 0 | D |
| Employee Stock Option (Right to Buy)F2,F3 | $5.13 | Sep 20, 2017 | A | 967 | A | — | Sep 20, 2027 | Common Stock | 967 | 967 | D |
| Employee Stock Option (Right to Buy)F5,F4 | $15.49 | Sep 20, 2017 | D | 12,501 | D | — | Feb 16, 2022 | Common Stock | 12,501 | 0 | D |
| Employee Stock Option (Right to Buy)F5,F3,F6 | $5.13 | Sep 20, 2017 | A | 3,444 | A | — | — | Common Stock | 3,444 | 3,444 | D |
| Employee Stock Option (Right to Buy)F8,F7 | $16.73 | Sep 20, 2017 | D | 24,452 | D | — | Feb 15, 2023 | Common Stock | 24,452 | 0 | D |
| Employee Stock Option (Right to Buy)F8,F3,F6 | $5.13 | Sep 20, 2017 | A | 6,609 | A | — | — | Common Stock | 6,609 | 6,609 | D |
| Employee Stock Option (Right to Buy)F10,F9 | $47.55 | Sep 20, 2017 | D | 14,000 | D | — | Mar 14, 2024 | Common Stock | 14,000 | 0 | D |
| Employee Stock Option (Right to Buy)F10,F3,F6 | $5.13 | Sep 20, 2017 | A | 1,541 | A | — | — | Common Stock | 1,541 | 1,541 | D |
| Employee Stock Option (Right to Buy)F12,F11 | $41.14 | Sep 20, 2017 | D | 12,000 | D | — | Mar 12, 2025 | Common Stock | 12,000 | 0 | D |
| Employee Stock Option (Right to Buy)F12,F3,F6 | $5.13 | Sep 20, 2017 | A | 2,073 | A | — | — | Common Stock | 2,073 | 2,073 | D |
| Employee Stock Option (Right to Buy)F14,F13 | $7.10 | Sep 20, 2017 | D | 13,500 | D | — | Mar 4, 2026 | Common Stock | 13,500 | 0 | D |
| Employee Stock Option (Right to Buy)F14,F3,F6 | $5.13 | Sep 20, 2017 | A | 8,941 | A | — | — | Common Stock | 8,941 | 8,941 | D |
Explanation of responses
- F1The shares subject to the Option fully vested on May 18, 2015.
- F10On September 20, 2017, the Issuer cancelled, pursuant to the Issuer's option exchange program, an Option for 14,000 shares of FLDM common stock granted to the Reporting Person on March 14, 2014. In exchange, the Reporting Person received a replacement Option, for 1,541 shares, having an exercise price of $5.13 per share.
- F11The Option provided for vesting of 2/48th of the shares subject to the Option on March 12, 2015 and forty-six equal monthly installments beginning on April 1, 2015.
- F12On September 20, 2017, the Issuer cancelled, pursuant to the Issuer's option exchange program, an Option for 12,000 shares of FLDM common stock granted to the Reporting Person on March 12, 2015. In exchange, the Reporting Person received a replacement Option, for 2,073 shares, having an exercise price of $5.13 per share.
- F13The Option provided for vesting in forty-eight equal monthly installments beginning February 1, 2016.
- F14On September 20, 2017, the Issuer cancelled, pursuant to the Issuer's option exchange program, an Option for 13,500 shares of FLDM common stock granted to the Reporting Person on March 4, 2016. In exchange, the Reporting Person received a replacement Option, for 8,941 shares, having an exercise price of $5.13 per share.
- F2On September 20, 2017, the Issuer cancelled, pursuant to the Issuer's option exchange program, an Option for 3,334 shares of FLDM common stock granted to the Reporting Person on May 18, 2011. In exchange, the Reporting Person received a replacement Option, for 967 shares, having an exercise price of $5.13 per share.
- F31/12th of the total number of shares underlying the Option will vest on February 20, 2018, and 1/12th of the total number of shares underlying the Option granted will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date.
- F4The shares subject to the Option fully vested on January 1, 2016.
- F5On September 20, 2017, the Issuer cancelled, pursuant to the Issuer's option exchange program, an Option for 12,501 shares of FLDM common stock granted to the Reporting Person on February 17, 2012. In exchange, the Reporting Person received a replacement Option, for 3,444 shares, having an exercise price of $5.13 per share.
- F6The Option expiration date is September 20, 2027.
- F7The shares subject to the Option fully vested on January 1, 2017.
- F8On September 20, 2017, the Issuer cancelled, pursuant to the Issuer's option exchange program, an Option for 24,452 shares of FLDM common stock granted to the Reporting Person on February 15, 2013. In exchange, the Reporting Person received a replacement Option, for 6,609 shares, having an exercise price of $5.13 per share.
- F9The Option provided for vesting in forty-eight equal monthly installments beginning January 1, 2014.